Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Context Therapeutics Inc.

NAS: CNTX

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Context Therapeutics Inc.

Market open

 --Real time quotes

Jun 9, 2023, 11:41 a.m.

CNTX
/zigman2/quotes/228313454/composite

$

1.19

Change

-0.12 -9.10%

Volume

Volume 69,516

Real time quotes

/zigman2/quotes/228313454/composite

Previous close

$ 1.31

$ 1.19

Change

-0.12 -9.10%

Day low

Day high

$1.18

$1.31

Open

52 week low

52 week high

$0.47

$2.52

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Context Therapeutics Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 2019202020212022 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A ----9,268
COGS excluding D&A -----
Depreciation & Amortization Expense ----9,268
Depreciation -----
Amortization of Intangibles -----
Gross Income ----(9,268)
2019202020212022 5-year trend
SG&A Expense -5.38M2.57M7.44M14.87M
Research & Development -2.41M1.64M3.81M7.09M
Other SG&A -2.97M930,6673.63M-
Other Operating Expense -----
Unusual Expense -(93,365)(9.88M)2.95M500,000
EBIT after Unusual Expense -(5.28M)7.31M(10.39M)(15.38M)
Non Operating Income/Expense ----(2,000)
Non-Operating Interest Income ----547,268
Equity in Affiliates (Pretax) -----
Interest Expense -1.1M661,22464,240-
Gross Interest Expense -1.1M661,22464,240-
Interest Capitalized -----
Pretax Income -(6.38M)6.64M(10.46M)(14.84M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(6.38M)6.64M(10.46M)(14.84M)
Minority Interest Expense -----
Net Income -(6.38M)6.64M(10.46M)(14.84M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(6.38M)6.64M(10.46M)(14.84M)
Preferred Dividends -----
Net Income Available to Common -(6.38M)6.64M(10.46M)(14.84M)
EPS (Basic) -(0.58)0.61(0.65)(0.93)
Basic Shares Outstanding -10.96M10.96M15.97M15.97M
EPS (Diluted) -(0.58)0.61(0.65)(0.93)
Diluted Shares Outstanding -10.96M10.96M15.97M15.97M
EBITDA -(5.38M)(2.57M)(7.44M)(14.87M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.